Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Extragenital Chlamydia and Gonorrhea Among Community Venue-Attending Men Who Have Sex with Men - Five Cities, United States, 2017.

Johnson Jones ML, Chapin-Bardales J, Bizune D, Papp JR, Phillips C, Kirkcaldy RD, Wejnert C, Bernstein KT; National HIV Behavioral Surveillance Sexually Transmitted Infection Study Group.

MMWR Morb Mortal Wkly Rep. 2019 Apr 12;68(14):321-325. doi: 10.15585/mmwr.mm6814a1.

2.

Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use.

Olesen SW, Torrone EA, Papp JR, Kirkcaldy RD, Lipsitch M, Grad YH.

J Infect Dis. 2019 Jan 29;219(4):619-623. doi: 10.1093/infdis/jiy551.

PMID:
30239814
3.

Improving STD service delivery: Would American patients and providers use self-tests for gonorrhea and chlamydia?

Pearson WS, Kreisel K, Peterman TA, Zlotorzynska M, Dittus PJ, Habel MA, Papp JR.

Prev Med. 2018 Oct;115:26-30. doi: 10.1016/j.ypmed.2018.08.007. Epub 2018 Aug 7.

PMID:
30096329
4.

Performance of Chlamydia trachomatis OmcB Enzyme-Linked Immunosorbent Assay in Serodiagnosis of Chlamydia trachomatis Infection in Women.

Gupta K, Brown L, Bakshi RK, Press CG, Chi X, Gorwitz RJ, Papp JR, Geisler WM.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00275-18. doi: 10.1128/JCM.00275-18. Print 2018 Sep.

5.

Preparing for the Chlamydia and Gonorrhea Self-Test.

Peterman TA, Kreisel K, Habel MA, Pearson WS, Dittus PJ, Papp JR.

Sex Transm Dis. 2018 Mar;45(3):e7-e9. doi: 10.1097/OLQ.0000000000000737.

PMID:
29420452
6.

Susceptibility of Neisseria gonorrhoeae to Gentamicin-Gonococcal Isolate Surveillance Project, 2015-2016.

Mann LM, Kirkcaldy RD, Papp JR, Torrone EA.

Sex Transm Dis. 2018 Feb;45(2):96-98. doi: 10.1097/OLQ.0000000000000693.

7.

Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment.

Papp JR, Rowlinson MC, O'Connor NP, Wholehan J, Razeq JH, Glennen A, Ware D, Iwen PC, Lee LV, Hagan C.

J Med Microbiol. 2018 Jan;67(1):68-73. doi: 10.1099/jmm.0.000651. Epub 2017 Dec 8.

PMID:
29219803
8.

Antimicrobial Drug Prescription and Neisseria gonorrhoeae Susceptibility, United States, 2005-2013.

Kirkcaldy RD, Bartoces MG, Soge OO, Riedel S, Kubin G, Del Rio C, Papp JR, Hook EW 3rd, Hicks LA.

Emerg Infect Dis. 2017 Oct;23(10):1657-1663. doi: 10.3201/eid2310.170488.

9.

Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.

Katz AR, Komeya AY, Kirkcaldy RD, Whelen AC, Soge OO, Papp JR, Kersh EN, Wasserman GM, O'Connor NP, O'Brien PS, Sato DT, Maningas EV, Kunimoto GY, Tomas JE.

Clin Infect Dis. 2017 Sep 15;65(6):918-923. doi: 10.1093/cid/cix485.

PMID:
28549097
10.

Population-attributable fraction of tubal factor infertility associated with chlamydia.

Gorwitz RJ, Wiesenfeld HC, Chen PL, Hammond KR, Sereday KA, Haggerty CL, Johnson RE, Papp JR, Kissin DM, Henning TC, Hook EW 3rd, Steinkampf MP, Markowitz LE, Geisler WM.

Am J Obstet Gynecol. 2017 Sep;217(3):336.e1-336.e16. doi: 10.1016/j.ajog.2017.05.026. Epub 2017 May 19.

11.

Immunoglobulin-Based Investigation of Spontaneous Resolution of Chlamydia trachomatis Infection.

Bakshi RK, Gupta K, Jordan SJ, Brown LT, Press CG, Gorwitz RJ, Papp JR, Morrison SG, Lee JY, Morrison RP, Geisler WM.

J Infect Dis. 2017 Jun 1;215(11):1653-1656. doi: 10.1093/infdis/jix194.

12.

Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA.

Papp JR, Abrams AJ, Nash E, Katz AR, Kirkcaldy RD, O'Connor NP, O'Brien PS, Harauchi DH, Maningas EV, Soge OO, Kersh EN, Komeya A, Tomas JE, Wasserman GM, Kunimoto GY, Trees DL, Whelen AC.

Emerg Infect Dis. 2017 May;23(5):830-832. doi: 10.3201/eid2305.170088.

13.

Considerations for Strengthening Surveillance of Neisseria gonorrhoeae Antimicrobial Resistance and Interpreting Surveillance Data.

Kirkcaldy RD, Schlanger K, Papp JR, Torrone EA.

Sex Transm Dis. 2017 Mar;44(3):154-156. doi: 10.1097/OLQ.0000000000000584. No abstract available.

14.

Comparing the disk-diffusion and agar dilution tests for Neisseria gonorrhoeae antimicrobial susceptibility testing.

Liu H, Taylor TH Jr, Pettus K, Johnson S, Papp JR, Trees D.

Antimicrob Resist Infect Control. 2016 Nov 24;5:46. eCollection 2016.

15.

In vitro growth of multidrug-resistant Neisseria gonorrhoeae isolates is inhibited by ETX0914, a novel spiropyrimidinetrione.

Papp JR, Lawrence K, Sharpe S, Mueller J, Kirkcaldy RD.

Int J Antimicrob Agents. 2016 Sep;48(3):328-30. doi: 10.1016/j.ijantimicag.2016.05.018. Epub 2016 Jul 12.

16.

Recovery of Neisseria gonorrhoeae from 4 commercially available transport systems.

Papp JR, Henning T, Khubbar M, Kalve V, Bhattacharyya S, Travanty E, Xavier K, Jones K, Rudrik JT, Gaynor A, Hagan C.

Diagn Microbiol Infect Dis. 2016 Oct;86(2):144-7. doi: 10.1016/j.diagmicrobio.2016.06.019. Epub 2016 Jun 24.

PMID:
27489119
17.

Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.

Kirkcaldy RD, Harvey A, Papp JR, Del Rio C, Soge OO, Holmes KK, Hook EW 3rd, Kubin G, Riedel S, Zenilman J, Pettus K, Sanders T, Sharpe S, Torrone E.

MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.

PMID:
27414503
18.

Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014.

Kirkcaldy RD, Hook EW 3rd, Soge OO, del Rio C, Kubin G, Zenilman JM, Papp JR.

JAMA. 2015 Nov 3;314(17):1869-71. doi: 10.1001/jama.2015.10347. No abstract available.

19.

Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained From Women and Men.

Kidd S, Moore PC, Kirkcaldy RD, Philip SS, Wiesenfeld HC, Papp JR, Kerndt PR, Venkatasubramanian L, Ghanem KG, Hook EW 3rd.

Sex Transm Dis. 2015 Aug;42(8):434-9. doi: 10.1097/OLQ.0000000000000312.

20.

In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae.

Pettus K, Sharpe S, Papp JR.

Antimicrob Agents Chemother. 2015 Apr;59(4):2443-5. doi: 10.1128/AAC.04127-14. Epub 2015 Jan 26.

21.

Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013.

Kirkcaldy RD, Soge O, Papp JR, Hook EW 3rd, del Rio C, Kubin G, Weinstock HS.

Antimicrob Agents Chemother. 2015 Feb;59(2):998-1003. doi: 10.1128/AAC.04337-14. Epub 2014 Dec 1.

22.

The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.

Kirkcaldy RD, Weinstock HS, Moore PC, Philip SS, Wiesenfeld HC, Papp JR, Kerndt PR, Johnson S, Ghanem KG, Hook EW 3rd.

Clin Infect Dis. 2014 Oct 15;59(8):1083-91. doi: 10.1093/cid/ciu521. Epub 2014 Jul 16.

23.

Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.

Kirkcaldy RD, Kidd S, Weinstock HS, Papp JR, Bolan GA.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv5-10. doi: 10.1136/sextrans-2013-051162.

PMID:
24243881
24.

Prevalence of Neisseria gonorrhoeae among persons 14 to 39 years of age, United States, 1999 to 2008.

Torrone EA, Johnson RE, Tian LH, Papp JR, Datta SD, Weinstock HS.

Sex Transm Dis. 2013 Mar;40(3):202-5. doi: 10.1097/OLQ.0b013e31827c5a71.

PMID:
23407466
25.

Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections.

Bachmann LH, Johnson RE, Cheng H, Markowitz L, Papp JR, Palella FJ Jr, Hook EW 3rd.

J Clin Microbiol. 2010 May;48(5):1827-32. doi: 10.1128/JCM.02398-09. Epub 2010 Mar 24.

26.

Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections.

Bachmann LH, Johnson RE, Cheng H, Markowitz LE, Papp JR, Hook EW 3rd.

J Clin Microbiol. 2009 Apr;47(4):902-7. doi: 10.1128/JCM.01581-08. Epub 2009 Feb 4.

27.

The rectal tonsil: a reaction to chlamydial infection?

Cramer SF, Romansky S, Hulbert B, Rauh S, Papp JR, Casiano-Colon AE.

Am J Surg Pathol. 2009 Mar;33(3):483-5. doi: 10.1097/PAS.0b013e31818ff45e. No abstract available.

PMID:
19065099
28.

Evaluation of the rapid BioStar optical immunoassay for detection of Chlamydia trachomatis in adolescent women.

Bandea CI, Koumans EH, Sawyer MK, Dover J, O'Connor A, Papp JR, Unger ER, Braxton J, Black CM.

J Clin Microbiol. 2009 Jan;47(1):215-6. doi: 10.1128/JCM.01338-08. Epub 2008 Nov 12.

29.

Sexually transmissible infections and prostate cancer risk.

Huang WY, Hayes R, Pfeiffer R, Viscidi RP, Lee FK, Wang YF, Reding D, Whitby D, Papp JR, Rabkin CS.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2374-81. doi: 10.1158/1055-9965.EPI-08-0173.

30.

The use and performance of oral-throat rinses to detect pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections.

Papp JR, Ahrens K, Phillips C, Kent CK, Philip S, Klausner JD.

Diagn Microbiol Infect Dis. 2007 Nov;59(3):259-64. Epub 2007 Jul 26.

PMID:
17662554
31.

Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002.

Datta SD, Sternberg M, Johnson RE, Berman S, Papp JR, McQuillan G, Weinstock H.

Ann Intern Med. 2007 Jul 17;147(2):89-96.

PMID:
17638719
32.

Incorporating adolescent females' perceptions of their partners' attitudes toward condoms into a model of female adolescent condom use.

Hogben M, Liddon N, Pierce A, Sawyer M, Papp JR, Black CM, Koumans EH.

Psychol Health Med. 2006 Nov;11(4):449-60.

PMID:
17129921
33.

Effect of specimen order on Chlamydia trachomatis and Neisseria gonorrhoeae test performance and adequacy of Papanicolaou smear.

Ghanem KG, Koumans EH, Johnson RE, Sawyer MK, Papp JR, Unger ER, Black CM, Markowitz LE.

J Pediatr Adolesc Gynecol. 2006 Feb;19(1):23-30.

PMID:
16472725
34.

Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents.

Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER.

Am J Epidemiol. 2005 Oct 1;162(7):668-75. Epub 2005 Aug 24.

PMID:
16120706
35.

Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.

Wang SA, Papp JR, Stamm WE, Peeling RW, Martin DH, Holmes KK.

J Infect Dis. 2005 Mar 15;191(6):917-23. Epub 2005 Feb 11. Review.

PMID:
15717267
36.

Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population.

Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, Markowitz L, Unger ER.

J Infect Dis. 2004 Jan 1;189(1):46-50. Epub 2003 Dec 22.

PMID:
14702152
37.
38.

Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002.

Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, Steece R, Markowitz LE, Devine OJ, Walsh CM, Wang S, Gunter DC, Irwin KL, DeLisle S, Berman SM.

MMWR Recomm Rep. 2002 Oct 18;51(RR-15):1-38; quiz CE1-4.

39.

Experimentally induced pneumonia in scid/beige mice, using a bovine isolate of Pasteurella haemolytica.

Thorn CE, Papp JR, Shewen PE, Stirtzinger T.

Comp Med. 2000 Apr;50(2):153-9.

PMID:
10857006
40.
41.

Chlamydia psittaci infection in sheep: a paradigm for human reproductive tract infection.

Papp JR, Shewen PE.

J Reprod Immunol. 1997 Oct;34(3):185-202. Review.

PMID:
9350636
42.

Localization of chronic Chlamydia psittaci infection in the reproductive tract of sheep.

Papp JR, Shewen PE.

J Infect Dis. 1996 Dec;174(6):1296-302.

PMID:
8940221
43.
44.
45.

Chlamydia psittaci infection and associated infertility in sheep.

Papp JR, Shewen PE, Gartley CJ.

Can J Vet Res. 1993 Jul;57(3):185-9.

46.
47.

Supplemental Content

Support Center